Table 5.
Effect of EEIP on serum enzymes and lipid proteins.
| Treatment groups | Cholesterol (mg/dl) | TGL (mg/dl) | AST (U/L) | ALT (U/L) | ALP (U/L) |
|---|---|---|---|---|---|
| G1 | 108.85 ± 3.05 | 136.85 ± 2.55 | 36.40 ± 1.65 | 31.28 ± 1.45 | 132.28 ± 2.08 |
| G2 | 146.95 ± 4.34a | 220.28 ± 4.40a | 78.6 ± 2.94a | 62.32 ± 2.60a | 265.30 ± 4.35a |
| G3 | 126.30 ± 3.84b | 169.15 ± 2.65b | 44.40 ± 1.72b | 34.52 ± 1.70b | 154.45 ± 2.40b |
| G4 | 117.26 ± 3.42b | 160.08 ± 2.55b | 42.44 ± 2.30b | 35.28 ± 1.55b | 162.45 ± 2.22b |
| G5 | 115.18 ± 3.38b | 156.25 ± 2.50b | 41.60 ± 2.20b | 34.90 ± 1.42b | 160.48 ± 2.18b |
| G6 | 113.36 ± 3.26b | 153.30 ± 2.46b | 40.90 ± 2.16b | 34.80 ± 1.38b | 158.45 ± 2.15b |
G1 – Normal control, G2 – Cancer control, G3 – Positive control, G4–G6 – Treatment control EEIP 100, 200, 400 mg/kg respectively, Total Cholesterol (TC), Triglycerides (TGL), Aspartate amino Transferase (AST), Alanine amino Transferase (ALT), Alkaline phosphatase (ALP), U/L – units per liter.
All values are expressed as mean ± SD for 6 animals in each group.
One-way ANOVA followed by Newman–Keuls multiple comparison test.
a
Values are significantly different from normal control (G1) at p < 0.01.
b
Values are significantly different from cancer control (G2) at p < 0.01.